SkilaMederi Announces Kilian Weiss as Chief Executive Officer and Dr. Richard Nichol as Chairman of the Board
SkilaMederi, a leading provider of key opinion leader (KOL) and launch management solutions using software and social network analytics serving the life science industry, is pleased to announce the appointment of Kilian Weiss as Chief Executive Officer (CEO) and Dr. Richard Nichol as Chairman of... - April 07, 2012
Skila and Mederi Announce Merger
Skila, a leading provider of fully managed “Solution as-a-Service” (SaaS) product launch and key opinion leader (KOL) management to pharmaceutical companies and Mederi AG of Frankfurt, Germany, a leading provider of pharmaceutical analytics and social network intelligence to life... - March 30, 2012
Skila Sponsoring at Pharma Marketing Excellence Europe 2011
Skila, a leading provider of fully managed “Solution” as-a-Service (SaaS) product launch management and KOL management to life sciences companies, is a sponsor and exhibitor at Pharma Marketing Europe 2011 in Berlin, Germany to showcase iLaunch, Skila’s unique solution to optimize control over product launches. - October 23, 2011
Dr. Richard Nichol Joins Skila’s Board of Directors
Skila, a leading provider of fully managed Software-as-a-Service (SaaS) product launch management and key opinion leader (KOL) management solutions to pharmaceutical and medical device companies, announced today that Dr. Richard Nichol, Ph.D. has joined the company’s Board of Directors,... - August 28, 2011
Drew McCartney, Operating Committee Member of BelHealth, Joins Skila as Chief Executive Officer
Skila, a leading provider of fully managed Software-as-a-Service (SaaS) product launch management and key opinion leader (KOL) management solutions to pharmaceutical and medical device companies, is pleased to announce the appointment of Drew McCartney as CEO. Mr. McCartney has served in a variety of executive roles for companies in the medical devices, services and informatics industry and brings a sense of the client’s perspective that will be additive to the successes that Skila has achieved. - August 25, 2011
BelHealth Completes Acquisition of Skila
BelHealth Investment Partners, a healthcare-focused private equity buyout fund, announced today that it has completed its acquisition of Skila. Skila provides the healthcare industry with fully managed solutions that allow life science customers to focus on core business processes and engagement management across the lifecycle of product launches. BelHealth was founded in 2011 to target investment opportunities exclusively in the healthcare industry. - June 22, 2011
Skila’s iLaunch is the Solution of Choice for Top Client Product Launches
Skila announces another top pharmaceutical company has standardized on the Skila iLaunch solution adding a fourth product launch. Once other brand teams saw the initial launch team's success, they too wanted to achieve the same Skila solution impact. - June 19, 2011
Pharma Clients Once Again Extend and Expand Contracts with Skila
Pharmaceutical companies must do more with less, and as a result are turning to Skila to find better ways to collaborate around key business processes and workflows. - October 28, 2010
Two Top Pharma Clients Extend and Expand Contracts with Skila
Skila, the life science industry’s leading provider of knowledge agility and stakeholder collaboration management solutions, announces the extension and expansion of solution contracts with two top Pharma companies. The extension of the term and scope of Skila’s iAdvocate™ opinion... - June 18, 2010
Top Pharma Company Signs Contract with Skila for iKOL Solution
A global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health has selected Skila’s iKOL™ Expert Database solution. This company has identified iKOL™, the dynamic thought leader intelligence and insight tool, as the... - June 18, 2010
David Batten Appointed as President of Skila
Moish Tov, Chairman and CEO of Skila, is pleased to announce the appointment of David Batten to the newly created position of President. In this role, Batten will lead the organization's strategic planning, partnership and M&A initiatives. "I am pleased and excited to have David join our Executive leadership team and benefit from his experience and dedicated contributions towards the growth and future of our organization," says Tov. - June 03, 2010